The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Intratumoral vaccination with activated allogeneic dendritic cells in patients with newly diganosed metastatic renal cell carcinoma (mRCC).
Anders Magnusson
No relevant relationships to disclose
Anna Laurell
No relevant relationships to disclose
Maria Lonnemark
No relevant relationships to disclose
Einar Brekkan
No relevant relationships to disclose
Lars Adamson
Honoraria - Immunicum
Research Funding - Immunicum
Anna Tolf
No relevant relationships to disclose
Bengt Andersson
Stock Ownership - Immunicum
Research Funding - Immunicum
AnnaCarin Wallgren
Employment or Leadership Position - Immunicum (I)
Stock Ownership - Immunicum (B)
Rolf Kiessling
Consultant or Advisory Role - Active Biotech; Immunicum
Honoraria - Immunicum
Research Funding - Immunicum
Alex Karlsson-Parra
Employment or Leadership Position - Immunicum
Stock Ownership - Immunicum (I)
Research Funding - Immunicum